Royalty Pharma plcRPRXNASDAQ
Loading
EV to Sales HistoryNormalizing
Percentile Rank40
3Y CAGR+1.2%
5Y CAGR-1.6%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+1.2%/yr
vs -2.7%/yr prior
5Y CAGR
-1.6%/yr
Consistent
Acceleration
+3.9pp
Accelerating
Percentile
P40
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 10.52 | +31.9% |
| 2024 | 7.98 | +3.0% |
| 2023 | 7.74 | -23.7% |
| 2022 | 10.15 | +5.3% |
| 2021 | 9.65 | -15.5% |
| 2020 | 11.42 | -4.8% |
| 2019 | 11.99 | +5.7% |
| 2018 | 11.34 | -14.4% |
| 2017 | 13.26 | -20.3% |
| 2016 | 16.64 | - |